Tivantinib
Tivantinib is an orally bioavailable small molecule inhibitor of c-Met with potential antineoplastic activity.
| Catalog Number | T6117 |
| Alternative Name(s) | ARQ 197 |
| Research Area | Apoptosis|||Tyrosine Kinase/Adaptors |
| Molecular Formula | C23H19N3O2 |
| CAS# | 905854-02-6 |
| Purity | 99.95% |
| SMILES | C1Cc2cccc3c2n(C1)cc3[C@H]1[C@@H](C(=O)NC1=O)c1c[nH]c2ccccc12 |
| Size | 25 mg |
| Supplier Page | https://www.targetmol.com/compound/Tivantinib |
| Additional Information | https://www.targetmol.com/datasheet/T6117 |